{"pub_date": "2016-09-09T04:00:00+0000", "subsection_name": null, "lead_paragraph": "Seeking to force drug price competition in an expensive category, the company wants insurers to cover fewer anti-inflammatory drugs, at least as a first-line treatment.", "print_page": "1", "document_type": "article", "byline": {"person": [{"rank": 1, "organization": "", "lastname": "THOMAS", "firstname": "Katie", "role": "reported"}], "original": "By KATIE THOMAS"}, "multimedia": [{"width": 190, "height": 126, "url": "images/2016/09/09/business/09drugcosts/09drugcosts-thumbWide.jpg", "subtype": "wide", "legacy": {"wide": "images/2016/09/09/business/09drugcosts/09drugcosts-thumbWide.jpg", "widewidth": "190", "wideheight": "126"}, "type": "image"}, {"width": 600, "height": 400, "url": "images/2016/09/09/business/09drugcosts/09drugcosts-articleLarge.jpg", "subtype": "xlarge", "legacy": {"xlargewidth": "600", "xlargeheight": "400", "xlarge": "images/2016/09/09/business/09drugcosts/09drugcosts-articleLarge.jpg"}, "type": "image"}, {"width": 75, "height": 75, "url": "images/2016/09/09/business/09drugcosts/09drugcosts-thumbStandard-v2.jpg", "subtype": "thumbnail", "legacy": {"thumbnail": "images/2016/09/09/business/09drugcosts/09drugcosts-thumbStandard-v2.jpg", "thumbnailwidth": "75", "thumbnailheight": "75"}, "type": "image"}], "section_name": "Business Day", "headline": {"print_headline": "In Plan to Cut Cost of Drugs, Complications", "main": "A Push to Lower Drug Prices That Hit Insurers and Employers the Hardest"}, "source": "The New York Times", "blog": [], "word_count": "1292", "web_url": "http://www.nytimes.com/2016/09/09/business/express-scripts-urges-narrower-coverage-of-anti-inflammatory-drugs.html", "slideshow_credits": null, "news_desk": "Business", "type_of_material": "News", "snippet": "Seeking to force drug price competition in an expensive category, the company wants insurers to cover fewer anti-inflammatory drugs, at least as a first-line treatment....", "_id": "57d184d695d0e021d798510f", "abstract": "Express Scripts, nation's largest drug benefits manager, issues recommendation to insurers and employers that they cover fewer medications for inflammatory conditions, which has become costliest drug class in country and includes medications like Humira and Enbrel; company says intention of recommendation is to force drug companies to lower their prices through increased competition, but critics say plan is thinly-veiled way of increasing business for Express Script's mail-order specialty pharmacy, Accredo, ", "keywords": [{"rank": "1", "name": "organizations", "value": "Express Scripts Inc", "is_major": "Y"}, {"rank": "2", "name": "subject", "value": "Drugs (Pharmaceuticals)", "is_major": "Y"}, {"rank": "3", "name": "subject", "value": "Health Insurance and Managed Care", "is_major": "Y"}, {"rank": "4", "name": "subject", "value": "Prices (Fares, Fees and Rates)", "is_major": "N"}, {"rank": "5", "name": "subject", "value": "Enbrel (Drug)", "is_major": "N"}]}